The 14-3-3η blood test: A joint damage biomarker
14-3-3η, a clinically proven biomarker for earlier, more accurate RA diagnosis, prognosis and monitoring.
14-3-3η is available as a stand alone test at Quest Diagnostics and Labcorp, or as part of various autoimmune test panels for your convenience to order
The 14-3-3η Blood Test can identify Rheumatoid Arthritis earlier than traditional blood tests alone. 14-3-3η identifies 21% of early RA patients who test negative in traditional RF and CCP blood tests.
The 14-3-3η Blood Test can indicate poor prognosis that will likely result in significant joint deterioration.
Use the 14-3-3η Blood Test serially for monitoring treatment response
Quest Diagnostics
HCP Ordering Information
Test code: 91455
Comments are closed.